LU92915I2 - Ivermectine pour son usage dans le traitement de la rosacée - Google Patents

Ivermectine pour son usage dans le traitement de la rosacée Download PDF

Info

Publication number
LU92915I2
LU92915I2 LU92915C LU92915C LU92915I2 LU 92915 I2 LU92915 I2 LU 92915I2 LU 92915 C LU92915 C LU 92915C LU 92915 C LU92915 C LU 92915C LU 92915 I2 LU92915 I2 LU 92915I2
Authority
LU
Luxembourg
Prior art keywords
rosaceae
ivermectin
treatment
Prior art date
Application number
LU92915C
Other languages
English (en)
French (fr)
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33312271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92915(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0305048A external-priority patent/FR2854074B1/fr
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of LU92915I2 publication Critical patent/LU92915I2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
LU92915C 2003-04-24 2015-12-17 Ivermectine pour son usage dans le traitement de la rosacée LU92915I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0305048A FR2854074B1 (fr) 2003-04-24 2003-04-24 Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P 2003-05-09 2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en) 2003-04-24 2004-04-22 Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (1)

Publication Number Publication Date
LU92915I2 true LU92915I2 (fr) 2016-02-17

Family

ID=33312271

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92915C LU92915I2 (fr) 2003-04-24 2015-12-17 Ivermectine pour son usage dans le traitement de la rosacée

Country Status (15)

Country Link
US (6) US7550440B2 (ru)
EP (1) EP1620113B1 (ru)
JP (2) JP5711867B2 (ru)
KR (1) KR101187231B1 (ru)
AU (1) AU2004231323C1 (ru)
BR (1) BRPI0410503B8 (ru)
CA (1) CA2522579C (ru)
CY (2) CY1111797T1 (ru)
HU (1) HUS1500048I1 (ru)
LT (1) LTC1620113I2 (ru)
LU (1) LU92915I2 (ru)
MX (1) MXPA05011208A (ru)
PL (2) PL1620113T3 (ru)
RU (1) RU2350333C3 (ru)
WO (1) WO2004093886A1 (ru)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
MXPA05011208A (es) * 2003-04-24 2005-12-14 Galderma Sa Uso de ivermectina para el tratamiento de desordenes dermatologicos.
AU2003275509A1 (en) * 2003-05-25 2004-12-13 Eco Animal Health Ltd. Dimeticone-containing sustained formulation
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2883181B1 (fr) 2005-03-17 2007-05-18 Galderma Sa Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
FR2886851B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
FR2886852B1 (fr) * 2005-06-10 2007-11-23 Galderma Sa Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2886850B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2907013B1 (fr) * 2006-10-12 2012-09-21 Galderma Sa Produits de soin cutane a double compartiment comprenant de l'ivermectine, et leurs utilisations
CA2666365C (en) 2006-10-12 2016-08-09 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US20100093652A1 (en) * 2006-10-12 2010-04-15 Topaz Pharmaceuticals Inc. Preservative System for Emulsion-Based Therapeutic Topical Formulations
FR2907012B1 (fr) 2006-10-12 2012-09-21 Galderma Sa Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation
US8901163B2 (en) * 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
DE102007056424A1 (de) * 2007-11-23 2009-05-28 Neopharmacie Gmbh Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
JP2012513387A (ja) * 2008-12-23 2012-06-14 ガルデルマ・ソシエテ・アノニム 感水性の活性成分を含む、局所用医薬組成物
US8642665B2 (en) 2011-12-16 2014-02-04 Conopco, Inc. Environmentally friendly, low whitening compositions
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
FR3000397A1 (fr) * 2012-12-31 2014-07-04 Galderma Res & Dev Combinaison de laropiprant et d'ivermectine pour le traitement de la rosacee
CN102872066B (zh) 2012-10-19 2014-07-02 厦门大学 伊维菌素及其衍生物的用途
FR3003761B1 (fr) * 2013-03-29 2016-01-01 Galderma Sa Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
JP6513667B2 (ja) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド 局所用組成物およびそれを使用する方法
RU2669942C1 (ru) * 2013-11-29 2018-10-17 Галдерма Са Соединение семейства авермектина или семейства мильбемицина для лечения и/или профилактики атопического дерматита
CN104706584A (zh) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 一种伊维菌素脂肪乳浓缩液、其制备方法及用途
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016022066A1 (en) * 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
FR3026010B1 (fr) * 2014-09-18 2016-11-04 Galderma Sa Compositions comprenant un compose de la famille des avermectines et de la doxycycline pour le traitement de la rosacee
WO2016096795A1 (en) * 2014-12-15 2016-06-23 Galderma Sa Compound of the avermectin family for treating and/or preventing inflammatory dermatoses
WO2016096797A1 (en) 2014-12-15 2016-06-23 Galderma Sa Compound of the avermectin family in combination with an other active compound for treating and/or preventing inflammatory dermatoses
CN108136029B (zh) 2015-10-13 2020-12-25 盖尔德玛公司 包含一种或多种阿维菌素的稳定乳液的制备方法
US10849854B2 (en) 2015-10-13 2020-12-01 Galderma S.A. Process for preparing a composition comprising a high concentration of one or more avermectins
JP2019523291A (ja) 2016-08-04 2019-08-22 ネスレ スキン ヘルス エス アー 酒さを治療又は予防するための組成物及びその使用
WO2018060870A1 (en) * 2016-09-30 2018-04-05 Aurobindo Pharma Limited Pharmaceutical composition of ivermectin and process for preparation thereof
US11234959B2 (en) 2016-11-03 2022-02-01 Galderma Holding SA Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
EP3326614A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without solvents and propenetrating agents of avermectin compounds
EP3326608A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without solid fatty substances
EP3326609A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without gelling agents
KR20230031370A (ko) * 2017-06-12 2023-03-07 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도
PL3723739T3 (pl) 2017-12-15 2024-09-16 Tarsus Pharmaceuticals, Inc. Preparaty izoksazolinowe i ich zastosowanie w leczeniu zapalenia powiek
WO2020064843A1 (en) * 2018-09-28 2020-04-02 Galderma Research & Development Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses
US11312922B2 (en) 2019-04-12 2022-04-26 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner comprising a sulfonic acid-containing surfactant and methods of making and using the same
KR20220066068A (ko) * 2019-08-21 2022-05-23 팀버 파마슈티칼스, 인코포레이티드 활성 제제의 국소 전달을 위한 용매 전달 시스템
KR20220052474A (ko) 2020-10-21 2022-04-28 순천향대학교 산학협력단 주사증 진단을 위한 마이크로RNA-21-3p 및 이의 용도
KR102480430B1 (ko) 2020-10-21 2022-12-21 순천향대학교 산학협력단 주사증 진단을 위한 마이크로RNA-31-5p 및 이의 용도
US11291679B1 (en) * 2021-03-22 2022-04-05 Mountain Valley Md Inc. Injectable, infusable, instillable ivermectin adjuvant for cancer therapies
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5952371A (en) * 1996-10-16 1999-09-14 Merck & Co., Inc. Triterpene derivatives with immunosuppressant activity
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6310968B1 (en) * 1998-11-24 2001-10-30 Picker International, Inc. Source-assisted attenuation correction for emission computed tomography
IL144561A0 (en) * 1999-01-25 2002-05-23 Optime Therapeutics Inc Liposome compositions and methods for treating pests utilizing the same
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
DE10063946A1 (de) * 2000-12-20 2002-07-04 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2,2'-p-Phenylen-bis(3,1-benzoxazin-4-on) enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
AU2003215011A1 (en) * 2002-02-08 2003-09-02 Mcneil-Ppc, Inc. Topical ivermectin composition
CN1649578A (zh) * 2002-03-04 2005-08-03 戴弗根斯公司 杀线虫的脂肪酸和脂肪酸酯相关化合物
MXPA05011208A (es) * 2003-04-24 2005-12-14 Galderma Sa Uso de ivermectina para el tratamiento de desordenes dermatologicos.
FR2867684B1 (fr) 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme

Also Published As

Publication number Publication date
US8080530B2 (en) 2011-12-20
US8470788B2 (en) 2013-06-25
AU2004231323A1 (en) 2004-11-04
KR20060004667A (ko) 2006-01-12
JP2006524212A (ja) 2006-10-26
CA2522579A1 (en) 2004-11-04
US20090252797A1 (en) 2009-10-08
US20130209381A1 (en) 2013-08-15
PL1620113T3 (pl) 2011-10-31
US20120258062A1 (en) 2012-10-11
RU2005136438A (ru) 2006-05-27
CY2016031I2 (el) 2017-03-15
CY1111797T1 (el) 2015-10-07
JP5538461B2 (ja) 2014-07-02
BRPI0410503B8 (pt) 2021-05-25
BRPI0410503B1 (pt) 2018-07-10
US8598129B2 (en) 2013-12-03
KR101187231B1 (ko) 2012-10-02
CY2016031I1 (el) 2017-03-15
JP5711867B2 (ja) 2015-05-07
US20120077766A1 (en) 2012-03-29
BRPI0410503A (pt) 2006-06-20
AU2004231323B2 (en) 2009-12-10
US20060100165A1 (en) 2006-05-11
CA2522579C (en) 2012-08-28
WO2004093886A1 (en) 2004-11-04
RU2350333C3 (ru) 2018-08-24
MXPA05011208A (es) 2005-12-14
AU2004231323C1 (en) 2016-11-03
EP1620113B1 (en) 2011-07-13
HUS1500048I1 (hu) 2017-10-30
US8093219B2 (en) 2012-01-10
EP1620113A1 (en) 2006-02-01
US8415311B2 (en) 2013-04-09
US20090227668A1 (en) 2009-09-10
RU2350333C2 (ru) 2009-03-27
LTC1620113I2 (lt) 2018-02-26
US7550440B2 (en) 2009-06-23
JP2012126738A (ja) 2012-07-05
PL378932A1 (pl) 2006-06-12

Similar Documents

Publication Publication Date Title
LU92915I2 (fr) Ivermectine pour son usage dans le traitement de la rosacée
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
CY2016035I2 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
ATE289514T1 (de) Vaginalpflegezusammensetzung
DE60328797D1 (de) Blutbehandlungsgerät
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
DE602004015286D1 (de) Wäschebehandlungsmittel
FR2852392B1 (fr) Composition de fixation tissulaire
DK1651044T3 (da) Flydende præparat
DK1638502T3 (da) Dentalt behandlingselement
FR2899476B1 (fr) Association du mazindol dans le traitement du deficit de l'attention/hyperactivite
FR2864552B1 (fr) Traitement de surface par hydroxysulfate
DE602004017075D1 (de) Optometrisches Instrument
DK1678085T3 (da) Fluidbehandlingsindretning
DE60223576D1 (de) Hautbehandlungszusammensetzung
ATE399523T1 (de) Haarbehandlungszusammensetzung
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
ATA13602003A (de) Therapeutisches behandlungsgerät
ITMI20030647A1 (it) Dispositivo per il trattamento di sangue in circolazione extracorporea
DE602004015552D1 (de) Körperfettmessgerät
DE602004004262D1 (de) Ultraschallbehandlung von gewebematrices
DE60222664D1 (de) Hautbehandlungsmittel
DE502004005180D1 (de) Stereomikroskop
DE602004000627D1 (de) Hautreinigungsmittel